Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2013 Jul;56(2-3):200-5.
doi: 10.1007/s12026-013-8429-4.

Unraveling the soul of autoimmune diseases: pathogenesis, diagnosis and treatment adding dowels to the puzzle

Editorial

Unraveling the soul of autoimmune diseases: pathogenesis, diagnosis and treatment adding dowels to the puzzle

S Colafrancesco et al. Immunol Res. 2013 Jul.

Abstract

The pathogenesis of autoimmune diseases (ADs) is characterized by a complex interaction between genetic, immune defects, environmental and hormonal factors. The concept of "mosaic of autoimmunity" deals with the multi-factorial origin and diversity of expression of ADs in humans. Genetic leads to a predisposition in developing an autoimmune syndrome, but the presence of an external or endogenous environmental factor, recently called "exposome," is essential in triggering the immune response. Infections as well as the expositions to different other external environmental agents have been identified as potential trigger for ADs. A new syndrome, namely the autoimmune/inflammatory syndrome induced by adjuvants, has recently been defined alluding to the key role of adjuvant in inducing an immune-mediated condition. Aluminum and silicone, respectively found in vaccines and breast implants, are the most commonly known adjuvants charged with development of autoimmune conditions. Similarly to playing chess, unraveling the pathogenesis of autoimmune diseases with every new discovery is adding a move to the game aiming at checkmating ADs.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Immunol Res. 2013 Jul;56(2-3):362-70 - PubMed
    1. Immunol Res. 2013 Jul;56(2-3):382-9 - PubMed
    1. Immunol Res. 2013 Jul;56(2-3):390-7 - PubMed
    1. Immunol Res. 2013 Jul;56(2-3):341-7 - PubMed
    1. Acta Reumatol Port. 2011 Jan-Mar;36(1):10-2 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources